Bethesda, MD: The Federation of American Societies for Experimental Biology (FASEB) is pleased to announce its release of the latest edition of the Breakthroughs in Bioscience series: "Conquering Cancer with Drugs from Nature's Medicine Cabinet". Also available as a downloadable podcast, the article is the second of a two-part series that discusses the basic research foundations of the development of natural product-derived medicines (see part one here) and specifically focuses on cancer treatments.
In 1992, the Food and Drug Administration's (FDA) approval of Taxol, which derives from the Pacific yew tree, increased the five-year survival rate of metastatic ovarian cancer patients from 20 to 80 percent. More recently, seven anti-cancer drugs resulting from natural compounds were approved by the FDA, while seven more are currently in the drug-development pipeline.
The Breakthroughs in Bioscience series is a collection of illustrated articles, published by FASEB, that highlight the recent developments in basic biomedical research and explain how they impact medicine and human health. To obtain free copies of these publications, visit the FASEB Breakthroughs in Bioscience web site at http://www.faseb.org/break-throughs or contact FASEB's Office of Public Affairs at 301.634.7650.
FASEB is composed of 26 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Contact Person: Lawrence Green (email@example.com)